evidence card · statins_primary_high_risk
Statins reduce cardiovascular events in primary prevention in moderate-to-high risk adults
H5
▲ supports
stakes critical
4 posts scored
·
across 3 accounts
·
3 sources
Summary
JUPITER, HOPE-3, meta-analyses. Absolute benefit scales with baseline risk; small in very low-risk groups.
Five-score assessment
Scores not yet assigned for this card. (Legacy card; will be populated on next refinement.)
Scope
Population
adults with elevated 10-year ASCVD risk (typically >=7.5-10%)
Intervention
statin therapy
Outcome
ASCVD events
Not supported for
- low-risk young adults with no risk factors
- universal population